Michael Sheffery

Dr. Michael B. Sheffery is on the Board of Directors at Teva Biopharmaceuticals USA, Inc. and YM BioSciences USA, Inc. Dr. Sheffery was previously employed as a Non-Executive Director by argenx SE, an Independent Director by BTHC VI, Inc, an Independent Director by Supernus Pharmaceuticals, Inc., a Head-Laboratory by New York Cancer Hospital, a Member-Supervisory Board by Affimed NV, a Member-Supervisory Board by Affimed NV Niederlassung Deutschland, a Partner Emeritus by OrbiMed Advisors Private Equity, and a Member-Supervisory Board by Pieris AG.
He also served on the board at BTHC VI, Inc., Biosynexus, Inc., Memory Pharmaceuticals Corp.
and NeoGenesis Pharmaceuticals, Inc. He received his undergraduate degree from Princeton University and a doctorate degree from Princeton University.